Bellevue Group’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $132M | Buy |
|
|||||
|
2025
Q4 | $136M | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $334K | Sell |
|
|||||
|
2023
Q4 | $653K | Sell |
|
|||||
|
2023
Q3 | $978K | Buy |
|
|||||
|
2023
Q2 | $1.06M | Sell |
|
|||||
|
2023
Q1 | $1.17M | Hold |
|
|||||
|
2022
Q4 | $1.35M | Hold |
|
|||||
|
2022
Q3 | $946K | Sell |
|
|||||
|
2022
Q2 | $567K | Buy |
|